Navigation Links
Former Johnson & Johnson Executive Gives Big Voice to Small Companies
Date:1/15/2009

Big Pharma Perspective Gives Edge to Private Firms

PHILADELPHIA, Jan. 15 /PRNewswire/ -- Michael Parks, former Vice President of Corporate Communications for Centocor, Inc., an operating company of Johnson & Johnson (J&J) today announced the launch of a public relations consultancy, Pitch360 Incorporated (www.pitch360inc.com). Pitch360 is a public relations, marketing communications, and issues management consultancy that leverages its vast pharmaceutical and biotechnology experience to transform the way companies communicate to their customers, key stakeholders, and mainstream and social media.

"After nearly 15 years serving the pharma industry and growing from that experience, I wanted to design a consultancy that specifically caters to the next generation of companies that promise breakthrough therapies for patients," said Michael Parks, Founder and President of Pitch360 Inc. "In particular, small companies can now bypass the trial-and-error process of their predecessors and immediately put breakthrough strategies to work for their business."

Created with the changing needs of the industry in mind, Pitch360 uses its relationships with a wide variety of stakeholders in the pharmaceutical and biotech industry to stay ahead of 'status quo' thinking so that they can bring forward ideas that rise above that of their competition. Through well established networks of healthcare providers, experts in government, regulatory and policy matters; creative media talent, as well the healthcare, business, mainstream and social media; Pitch360 has the tools and experience necessary to provide breakthrough strategies that companies can implement to deliver on their business objectives.

"In today's economy, companies are looking for value and innovation," said Mr. Parks. "Pitch360 provides affordable communications solutions using breakthrough strategies that will deliver outstanding results."

Pitch360 has a wide variety of services available for companies and not-for-profit groups, including strategic counseling, issues management, and investor relations and delivers these services with outstanding customer service and support. Pitch360 provides specialty services for companies of all sizes.

ABOUT THE FOUNDER

Prior to founding Pitch360 in 2008, Michael Parks was the Vice President of Corporate Communications at Centocor, Inc., an operating company of Johnson & Johnson. In this role, he acted as the company's Chief Communications Officer with communications responsibility for the protection and enhancement of the company's image and products from a commercial, research & development, and manufacturing perspective. Prior to that, Michael held executive positions at Pharmacia Corporation and Searle Pharmaceuticals, and led efforts related to the launch of a number of blockbuster products. Michael has been a pioneer in social media for the pharma industry and was also the Executive Producer of the groundbreaking documentary, INNERSTATE, a film that chronicled the devastating impact of chronic disease and the promise of innovation. This documentary was a first for the pharmaceutical industry and just part of Michael's broad portfolio of innovative approaches to effectively communicating complex issues to a wide variety of audiences.


'/>"/>
SOURCE Pitch360 Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Access MediQuip Appoints Former Priority Healthcare CEO to Chairman of the Board
2. Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla
3. VirtualHealth Technologies, Inc. Appoints Former DEA Assistant Administrator to its Advisory Board
4. LCA-Visions Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders
5. Comment of Senator Patrick Leahy (D-Vt.) on President-elect Obamas Choice of Former Senator Tom Daschle to Head The Department of Health and Human Services and A New White House Office of Health Reform
6. LCA-Visions Former Executive Management Urge Board of Directors to Immediately Call Special Shareholder Meeting to Approve Poison Pill
7. Former Mayor of Indianapolis to Serve as a Senior Strategic Advisor to McKenna Long & Aldridge LLPs Global Infrastructure Finance and Public-Private Partnerships Practice
8. Sweet Surprise: Even Former Critics Dispel Long-Held Myths About High Fructose Corn Syrup
9. 11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions
10. TomoTherapy Names Rafael Vaello Vice President of Global Sales : Former Philips Healthcare executive brings proven sales experience in oncology, imaging industries
11. 11.4% Shareholders & Former Executive Management of LCA-Vision Express Shock and Disbelief at Recent Adoption of Poison Pill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... , ... People across the U.S. are sharpening their pencils and honing their ... in which patients and their families pay tribute to a genetic counselor by nominating ... of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, ...
(Date:6/24/2016)... ... ... recruitment firm Slone Partners is pleased to announce the placement of Suzanne ... of North American Capital Sales at HTG Molecular . , In ... commercialization of the HTG EdgeSeq system and associated reagents in North America. , Headquartered ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
Breaking Medicine Technology: